None listed
Conditions
Interventions
Intervention1: Product 1 ( Sample Code : NRXT 263/1030 ): Patch of formulation was applied onto designated test site and retained till 24 hours.
The patch was removed after 24 hours.
Intervention2: Pr
Sponsors
Emami Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Subjects with skin type III to V. • Subjects willing to give a written informed consent. • Subjects willing to maintain the patch test in position for 24 hours. • Subject has not participated in a similar investigation in the past two weeks. • Subjects willing to come for regular follow up. • Subjects ready to follow instructions during the study period.
Exclusion criteria
Exclusion criteria: • Infection, allergy on the tested area • History of skin allergy antecedents or atopic subjects • History of hyper sensitivity to any component of the tested products • Athletes and subjects with history of excessive sweating • Cutaneous disease which may influence the study result • Chronic illness which may influence the cutaneous state. • Subjects on oral corticosteroid • Subjects participating in any other cosmetic or therapeutic trial. • Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| To gather safety information prior to a pilot study and/or larger study, in order to improve the quality and efficiency of the prospective studiesâ?? design.Timepoint: 9 days for each volunteer (5 visits) | — |
Primary
| Measure | Time frame |
|---|---|
| To evaluate the dermatological safety of the given investigational product/s on skin of healthy human volunteers by primary irritation patch testTimepoint: 9 days for each volunteer (5 visits) | — |
Countries
India
Contacts
Public ContactDr Harisha S
ICBio Clinical Research Pvt Ltd
Outcome results
None listed